Phyto-oestrogens and breast cancer

Challenging Spontaneous Quantum Collapse with the XENONnT Dark Matter Detector.

Physical review letters·2026

WIMP Dark Matter Search Using a 3.1 Tonne-Year Exposure of the XENONnT Experiment.

Physical review letters·2025

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.

ESMO open·2025

Molecular constraints of sarcopenia in the ageing muscle.

Frontiers in aging·2025

Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.

ESMO open·2025

Search for Light Dark Matter in Low-Energy Ionization Signals from XENONnT.

Physical review letters·2025

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Oncoviruses at the Crossroads of Ageing and Cancer: Molecular Mechanisms and Key Signalling Pathways.

Reviews in medical virology·2026

A bibliometric analysis of research trends and hotspots regarding macrophage polarization in lung cancer.

Journal of thoracic disease·2026

Chromophobe renal cell carcinoma with sarcomatoid and rhabdoid differentiation in a patient with duplicated inferior vena cava: case report and literature review.

Journal of surgical case reports·2026

Lack of resolution of inflammation marks malignant pleural mesothelioma progression.

Cancer drug resistance (Alhambra, Calif.)·2026

USP5 silencing inhibits the proliferation of bladder cancer cells and induces cell apoptosis and ferroptosis by destabilizing COL14A1 expression.

Translational andrology and urology·2026

Signaling pathways and ion channels in osteoarthritis: a review of recent advances.

Frontiers in immunology·2026

Related Experiment Videos

Phyto-oestrogens and breast cancer

Related Concept Videos

Challenging Spontaneous Quantum Collapse with the XENONnT Dark Matter Detector.

WIMP Dark Matter Search Using a 3.1 Tonne-Year Exposure of the XENONnT Experiment.

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.

Molecular constraints of sarcopenia in the ageing muscle.

Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.

Search for Light Dark Matter in Low-Energy Ionization Signals from XENONnT.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Oncoviruses at the Crossroads of Ageing and Cancer: Molecular Mechanisms and Key Signalling Pathways.

A bibliometric analysis of research trends and hotspots regarding macrophage polarization in lung cancer.

Chromophobe renal cell carcinoma with sarcomatoid and rhabdoid differentiation in a patient with duplicated inferior vena cava: case report and literature review.

Lack of resolution of inflammation marks malignant pleural mesothelioma progression.

USP5 silencing inhibits the proliferation of bladder cancer cells and induces cell apoptosis and ferroptosis by destabilizing COL14A1 expression.

Signaling pathways and ion channels in osteoarthritis: a review of recent advances.

Related Experiment Videos

Phyto-oestrogens and breast cancer

Related Concept Videos

Related Articles